PtdIns(4)P) in vesicle-mediated protein transport from the trans-Golgi network (TGN) was first described in the budding yeast Saccharomyces cerevisiae 1-3 . However, the identity of downstream effectors of PtdIns(4)P in this system has been elusive. Here, we show that Drs2p, a type IV P-type ATPase required for phospholipid translocase (flippase) activity and transport vesicle budding from the TGN 4-8 , is an effector of PtdIns(4)P. Drs2p-dependent flip of a fluorescent phosphatidylserine analogue across purified TGN membranes requires synthesis of PtdIns(4)P by the phosphatidylinositol-4-kinase (PI(4)K) Pik1p. PtdIns(4)P binds to a regulatory domain in the C-terminal tail of Drs2p that has homology to a split PH domain and is required for Drs2p activity. In addition, basic residues required for phosphoinositide binding overlap a previously mapped binding site for the ArfGEF Gea2p 9 . ArfGEF binding to this C-terminal domain also stimulates flippase activity in TGN membrane preparations. These interactions suggest the presence of a coincidence detection system used to activate phospholipid translocation at sites of vesicle formation.
Phosphoinositides exert control over numerous aspects of cell physiology, including signal transduction cascades, cytoskeletal dynamics, cell motility and protein trafficking [10] [11] [12] . In the latter role, phosphoinositides provide unique signposts that help to establish organelle identity through recruitment of effectors 13 . For example, PtdIns(4)P is found predominantly in TGN membranes where, in mammalian cells, it recruits AP-1, GGA and epsinR adaptors to facilitate budding of clathrin-coated vesicles, as well as a glucosylceramide transfer protein (FAPP), which is required for budding of exocytic carriers [14] [15] [16] [17] [18] . In S. cerevisiae, GGA clathrin adaptors and oxysterol binding proteins require Pik1p activity for TGN association [19] [20] [21] , but other effectors must be present to explain the spectrum of protein transport defects observed in pik1 ts cells [1] [2] [3] 22 . Drs2p activity is required for the formation of one class of exocytic vesicles, as well as AP-1/clathrin-coated vesicles 4, 7 . The discovery of a strong genetic interaction between drs2 and pik1 ts suggested a potential biochemical relationship between PtdIns(4)P and flippase activity at the TGN 23 .
To determine whether Drs2p acts upstream of Pik1p to facilitate PtdIns(4)P synthesis, we compared phosphoinositide levels in wildtype cells and drs2∆ cells (which lack Drs2p) that had been labelled with myo-3 H-inositol. No significant differences were observed between drs2∆ and wild-type cells in the relative amount of any of the four major phosphoinositide species that are produced in S. cerevisiae, including PtdIns(4)P. In addition, membrane localization of Osh1-PH-GFP, which specifically binds PtdIns(4)P in the TGN 21 , was also unaffected by loss of Drs2p (Fig. 1) . Thus, Drs2p is not required for the synthesis of PtdIns(4)P at the TGN, and does not influence the synthesis of any other phosphoinositide.
Next we tested whether PtdIns(4)P influences Drs2p-dependent phospholipid flippase activity. TGN membranes were purified from wild-type cells and cells carrying temperature-sensitive (ts) alleles of DRS2 (drs2 ts ) or PIK1 (pik1 ts ), which encode proteins that are functional at 27 °C but lose activity at the nonpermissive temperature of 37 °C. These strains were grown at 27 °C to maintain normal structure and function of the Golgi before purifying the TGN. The wildtype and pik1 ts membranes were first incubated with γ 32 P-ATP at 27 °C and 37 °C to determine whether the TGN membranes retained PI(4)K (pik1 ts ) activity and whether the temperature sensitive kinase could be inactivated by a temperature shift in vitro. Labelled lipids were extracted and separated by thin-layer chromatography. Robust synthesis of PtdIns(4)P was detected in both wild-type and pik1 ts TGN membranes at 27 °C. Compared with wild-type membranes, PtdIns(4)P production was significantly reduced, although not eliminated, in pik1 ts membranes incubated for 2 h at the non-permissive temperature of 37 °C ( Fig. 2a, b) . A small amount of PtdIns(3)P synthesis was detected in these membrane preparations, but synthesis of this lipid was not significantly altered by pik1 ts inactivation.
The wild-type, pik1 ts and drs2 ts TGN membranes were then assayed for Drs2p-dependent flippase activity at both the permissive and nonpermissive temperatures. NBD-phosphatidylserine (NBD-PS) was incorporated into the TGN membrane on ice. The presence of the NBD fluor and short acyl chain (6-carbon) in the sn-2 position renders this lipid sufficiently water soluble to allow selective incorporation into, and subsequent back-extraction from, the TGN cytosolic leaflet. Before incubation at higher temperature ( Fig. 2c -e, 0 h), 100% of the NBD-PS probe could be back-extracted onto fatty acid free bovine serum albumin (BSA), indicating that the probe resided in the cytosolic leaflet. However, during incubation at 27 °C or 37 °C without ATP, spontaneous flip-flop allowed a portion of the NBD-PS probe to slowly diffuse into the inner lumenal leaflet, where it was resistant to back-extraction by BSA. At 2 h, ATP was added to half of each membrane sample to stimulate the Drs2p-dependent flippase activity as well as synthesis of PtdIns(4)P. For wild-type, pik1 ts and drs2 ts membranes incubated at 27 °C, addition of ATP stimulated NBD-PS translocation to the cytosolic leaflet compared to the same membranes without ATP ( Fig. 2c , e, g). Wild-type membranes retained flippase activity at 37 °C (Fig. 2d) ; however, inactivation of PI(4)K by incubation of pik1 ts membranes at 37 °C markedly reduced the flippase activity in these membranes ( Fig. 2f ). As previously shown 6 , TGN membranes from a drs2 ts strain also showed a loss of NBD-PS flippase activity at the nonpermissive temperature of 37 °C (Fig. 2h ). To facilitate comparisons, the difference in the percentage of NBD-PS in the cytosolic leaflet of wild-type TGN membranes after 4 h at 37 °C with or without ATP was defined as 100% NBD-PS flippase activity ( Fig. 2d , asterisk) and used to normalize flippase assay results for other conditions tested (Fig. 3) .
The modest flippase activity remaining in pik1 ts membranes at 37 °C could be stimulated to near wild-type levels by incorporation of exogenous PtdIns(4)P (at 3.3% of the total endogenous phospholipid) into the TGN membrane ( Fig. 3a) . Thus, the Pik1p requirement was bypassed by addition of its lipid product. Addition of PtdIns(3)P also stimulated NBD-PS flippase activity, although not as potently as PtdIns(4)P, and PtdIns(5)P was least effective (Fig. 3a) . TGN membranes were also purified from strains carrying temperature-conditional alleles of the sole PI(3)K in S. cerevisiae (vps34 ts ). NBD-PS flippase activity in the TGN membranes from the vps34 ts strain was not significantly different from the wild-type ( Fig. 3a ). Addition of wortmannin, a PI(3)K inhibitor, modestly reduced flippase activity in wild-type membranes (Fig. 3b ). The most effective tool for eliminating phosphoinositide synthesis in the TGN membranes was the Sac1 phosphoinositide phosphatase domain from Inp53p. Addition of sufficient GST-Sac1 to destroy both PtdIns(3)P and PtdIns(4)P in the TGN membrane abrogated flippase activity in wild-type membranes, whereas GST alone had no effect (Fig. 3b ). These data indicate that the Drs2p-dependent flippase activity requires phosphoinositides and is primarily stimulated by PtdIns(4)P produced by Pik1p.
A mechanism for regulating Drs2p-dependent flippase activity by phosphoinositides was suggested by the following observations. We had previously found that the cytosolic carboxy-terminal tail (C-tail) of Drs2p is required for the function of Drs2p in protein trafficking from the Golgi in vivo 9, 24 . The C-tail sequences responsible for this essential function were mapped to residues 1259-1282, which overlap with a stretch of amino acids that are highly conserved in mammalian Drs2p homologues (1274-1296) and an ArfGEF binding site (1250-1270) 9 . More recently, we noticed a short region of homology between residues 1268-1289 in the Drs2p C-tail and part of the split PH domain (also called the GLUE domain) of Vps36p (Fig. 4a ). The R261 residue of Vps36p, associates directly with PtdIns(3)P and is within a loop amino-terminal to an α-helical segment of the split PH domain 25 . Within this region of homology, Drs2p has a patch of basic resides followed by a predicted α-helical segment. We hypothesized that this basic patch of residues (RMKKQR) within the functionally essential C-tail region leads to PtdIns(4)P-dependent regulation of Drs2p.
To test whether the basic patch can interact with phosphoinositides, we purified the membrane proximal two-thirds of the Drs2p C-tail (residues 1219-1305) containing either the wild-type basic patch (RMKKQR), a deletion of the basic patch (∆RMKKQR), or mutations of the basic residue to Ala (AMAAQA). This part of the Drs2p C-tail contains two other predicted α-helices ( Fig. 4a , boxes in the C-tail region) and based on the circular dichroism spectrum, the purified His6-tagged C-tail has significant α-helical content ( Supplementary  Information, Fig. S1 ). The wild-type (RMKKQR) C-tail bound specifically to phosphoinositides immobilized on nitrocellulose with a preference for PtdIns(4)P and PtdIns(3,4,5)P 3 ( Fig. 4b ; Supplementary  Information, Fig. S2a ). By contrast, binding of mono-and diphosphorylated phosphoinositides, and particularly PtdIns(4)P, was substantially reduced by the AMAAQA and ∆RMKKQR mutations. Binding of PtdIns(3,4,5)P 3 was unaffected by the AMAAQA mutations ( Fig. 4b ; Supplementary Information, Fig. S2a ); however this phosphoinositide is not produced in yeast and so the basis for this interaction was not further pursued. Among the other phospholipids tested, only the negatively charged PS and phosphatidic acid (PA) interacted with the wild-type C-tail above background levels ( Fig. 4b ; Supplementary  Information, Fig. S2a ). In binding assays with liposomes, the wildtype C-tail preferentially interacted with phosphatidylcholine (PC)/ PE membranes that contain 3 mol% PtdIns(4)P relative to control PC/ PE or PC/PE/PI liposomes. C-tail interaction was also observed with liposomes containing PtdIns(5)P, PtdIns(3)P and PS ( Supplementary  Information, Fig. S2b ).
If the C-tail interaction with phosphoinositides is required for Drs2p activity, then mutation of the basic residues in the context of full-length Drs2p should perturb the function of this protein in vivo. Plasmids carrying the drs2 alleles ( Fig. 4c ) were tested for their ability to complement the cold-sensitive growth defect of drs2∆. The drs2∆ strain carrying an empty plasmid control ( Fig. 4c, drs2∆) showed normal growth at 30 °C and a strong growth defect at 20 °C that is typical of cells lacking Drs2p activity. The wild-type DRS2 gene fully complemented the cold-sensitive growth defect. By contrast, drs2 alleles carrying the basic patch to Ala C-tail mutations (drs2-AMAAQA) or a deletion of the basic patch (drs2-∆RMKKQR) failed to fully complement the drs2∆ mutant. Deletion of the predicted α-helical segment homologous to Vps36p (drs2-∆GFAFSQAEE), or the Gea2p binding region (drs2-∆1250-1263), perturbed complementation, although not as markedly as mutation of the basic patch. A western blot showed no difference in the stability of the mutant Drs2 proteins, compared with wild-type Drs2p ( Supplementary  Information, Fig. S3a ).
To further assess the influence of the basic patch on Drs2p activity, we purified TGN membranes from wild-type, drs2-AMAAQA and drs2-∆RMKKQR strains to assay for NBD-PS flippase activity. An equivalent amount of Drs2p was recovered in each TGN sample, indicating that the basic patch is not required for TGN localization of Drs2p ( Supplementary Information, Fig. S3a ). However, NBD-PS flippase activity was strongly abrogated by mutation of the C-tail basic patch (Fig. 4d ). The drs2-∆RMKKQR mutant showed less activity than drs2-AMAAQA, consistent with the more severe growth defect of cells expressing drs2-∆RMKKQR relative to drs2-AMAAQA ( Fig. 4c, d) .
The RMKKQR basic patch overlaps a binding site for the Sec7 (exchange factor) domain of the ArfGEF Gea2p that we had previously mapped (Fig. 4a) 9 . Therefore, we tested the influence of the ∆RMKKQR and AMAAQA mutations on ArfGEF interaction. The basic patch deletion partially disrupted the Gea2p interaction, although the Ala mutations had no effect (Fig. 5a ). This observation suggests that the more severe effect of the ∆RMKKQR mutation on flippase activity and in vivo function was caused by loss of both phosphoinositide and ArfGEF interaction.
To test the influence of ArfGEF interaction with Drs2p on flippase activity, we purified TGN membranes from a yeast strain carrying a gea2 mutation (gea2-V698G) that was specifically selected in a reverse two-hybrid assay for loss of interaction with Drs2p 9 . The gea2-V698G TGN membranes were assayed at 37˚C with or without addition of the wild-type Gea2p-Sec7 domain (Fig. 5b) . Compared with wildtype membranes, flippase activity in gea2-V698G membranes was reduced by 50%. Addition of recombinant Gea2p-Sec7 domain to the mutant membranes significantly stimulated flippase activity.
The Drs2p C-tail interacts with both Gea1p and Gea2p 9 , a closely related essential pair of ArfGEFs, although Gea2p was primarily associated with the TGN membrane preparations ( Supplementary  Information, Fig. S3b ). Therefore, TGN membranes were purified from a pik1 ts gea2∆ double mutant and assayed for flippase activity. Compared with pik1 ts membranes at 27˚C, flippase activity in the pik1 ts gea2∆ membranes was reduced at 27˚C and nearly eliminated at 37˚C. Addition of PtdIns(4)P stimulated the flippase activity, whereas addition of Gea2p-Sec7 domain (200 ng) provided marginal stimulation. However, addition of both molecules provided a synergistic activation of Drs2p activity (Fig. 5c ). The ability of Gea2p to stimulate flippase activity is unlikely to be mediated by activation of Arf as no GTP was added to the reaction, addition of an inhibitor of the Arf exchange factor activity of Gea2p, brefeldin A, had no effect ( Supplementary Information, Fig. S3c ), and we could not detect an interaction between Arf and Drs2p 7 .
In further support of the in vivo significance of these interactions, we found that the drs2-∆1250-1263 allele, which is defective in binding Gea2p, is synthetically lethal with pik1 ts (Fig. 5d ). For this plasmid shuffle assay, a pik1 ts drs2∆ strain carrying wild-type DRS2 on a URA3-based plasmid was transformed with LEU2-based plasmids carrying the indicated drs2 allele. Failure to grow on 5-fluoro-orotic acid (5-FOA), which is toxic to cells retaining the URA3-DRS2 plasmid, indicates that drs2-∆1250-1263 cannot support viability of pik1 ts cells. By contrast, viable pik1 ts drs2-AMAAQA double mutants could be produced, and the drs2-∆RMKKQR allele produced only a few viable colonies. Thus, a strain with reduced PtdIns(4)P levels can tolerate a mutation in the Drs2p PtdIns(4)P binding site, but cannot tolerate loss of interaction between Drs2p and ArfGEF.
Our data indicate that the activity of Drs2p in the TGN is strongly stimulated by binding of PtdIns(4)P and ArfGEF to a regulatory domain in the Drs2p C-tail. The observed synergistic activation of Drs2p by PtdIns(4)P and ArfGEF suggests a coincidence detection system for constraining Drs2p activity to membrane sites enriched for both activators. Liposome-binding experiments suggest that PtdIns(4)P and Gea2p compete for interaction with the Drs2p C-tail ( Supplementary Information, Fig. S4 ). In this case, synergistic activation could be achieved if binding of one activator enhances the probability of interaction with the second, or if the interactions occur sequentially at the surface of the TGN membrane ( Supplementary  Information, Fig. S6 ). Conversely, it is also possible that in the context of full-length Drs2p in the TGN membrane, a tripartite complex of PtdIns(4)P, the Drs2p C-tail and Gea2p is stabilized to provide synergistic activation ( Supplementary Information, Fig. S6 ). The structural basis by which Drs2p C-tail interactions with phosphoinositides and ArfGEF stimulates flippase activity is unknown. For the plasma membrane Ca 2+ ATPase, the C-tail is an autoinhibitory domain and binding of calmodulin to the C-tail relieves autoinhibition and stimulates this pump 26 . It is possible that the Drs2p C-tail is also an autoinhibitory domain, although we have not been able to detect an inhibitory activity of the C-tail when added in trans to the TGN NBD-PS flippase assay ( Supplementary Information, Fig. S5 ). As an integral membrane protein required for a phospholipid flippase activity, Drs2p is a newly identified effector of phosphoinositides involved in protein trafficking. This work also describes the first function for an ArfGEF beyond the activation of Arf, and provides further evidence that Drs2p activity is coupled to the vesicle budding machinery of the TGN. To construct the pik1 ts drs2∆ pURA3-DRS2 strain (PNY15), we amplified the drs2∆::Kan r allele from ZHY615M2D using forward primer 5ʹ-TAATACCTTTAGTAGCTGTTGGGC-3ʹ with reverse primers 5ʹ-TGATGCCCTGGATACACCGGTGG-3ʹ. The PCR product was used to transform AAY104 harbouring pRS416-DRS2 to delete the chromosomal DRS2 allele. The yeast knockout strain collection was purchased from Resgen, Invitrogen.
Plasmid construction.
To construct pHis-Drs2p-CT, the wild-type sequence encoding amino acids 1219-1305 from the carboxyl terminus of Drs2p was PCR amplified using pRS315-DRS2 as template with forward primer (5ʹ-GAGTCATATGAGAGATTTTCTATGGAAGTAC-3ʹ) and reverse primer (5ʹ-AAGGGCTAGCCTATTGTAATTCACCGTACTTACC-3ʹ). The forward primer incorporated a non-templated NdeI site at the 5ʹ end of the PCR fragment, and the reverse primer incorporated a stop codon and an Nhe1 site at the 3ʹ end. The resulting PCR product was cloned into the NdeI-NheI sites of pET28a to generate pHis-Drs2CT. The pHis-Drs2CT(AMAAQA) and pHis-Drs2CT(∆RMKKQR) constructs were made by site-directed mutagenesis of pHis-Drs2CT using the Quick change-II kit (STRATAGENE) with the following primers: 5ʹ-GGCAAATCCTGCTTGTGCTGCCATTGCTTGCACTTGCCTC-3ʹ and5ʹ-GAGGCAAGTGCAAGCAATGGCAGCACAAGCAGGATTTG CC-3ʹ for the (AMAAQA) point mutations and 5ʹ-TGAAAA GGCAAAT-CCTTGCACTTGCCTCAC-3ʹ and 5ʹ-GTGAGGCA AGTGCAAGG ATTTG CC-TTTTCA-3ʹ for the (∆RMKKQR) deletion construct. A plasmid (pET15b-Sec7) expressing the Sec7 domain of Gea2p (residues 558-766) was a gift from Jonathan Goldberg (Memorial Sloan-Kettering Cancer Center, New York, NY).
To generate pRS315-drs2-AMAAQR and pRS315-drs2-∆RMKKQR vectors for complementation tests, we first amplified DRS2 sequences from an endogenous NcoI site to codon 1267 using forward primer 5ʹ-TATTACTT-GTCCATGGCTCCTGG-3ʹ with reverse primers 5ʹ-CCCACC ACGCG-TTGCTTGTGCTGCCATTGCTTGCACTTGC-3ʹ (AMAAQR) or 5ʹ-TATACGCGTTTGCACTTGCCTCACC (∆RMKKQR). The reverse primers incorporated MluI sites used to subclone the PCR fragments into pRS315-drs2 ∆1259-1273 30 digested with NcoI and MluI. pRS315-drs2-∆GFAFSQAEE is the same construct as pRS315-drs2-∆1274-1282 previously described 30 . The MluI site added two amino acids into Drs2-CT, including an Arg residue. To be certain this Arg did not contribute to phosphoinositide binding, we also constructed pRS315-drs2-AMAAQA, pRS315-drs2-∆RMKKQR and pRS315-drs2-∆1250-1263 vectors without the MluI site in the Drs2p C-tail. The NcoI to SalI region of pRS315-DRS2 was amplified and cloned into pGEM-T Easy vector, which was used as the template for site directed mutagenesis with the same primers used to mutagenize pHis-Drs2CT. The mutated NcoI and SalI fragment was used to replace the NcoI/SalI region of pRS315-drs2 ∆1259-1273. No difference was observed in complementation by these drs2 mutant alleles with or without the MluI site. Sequencing of the resulting plasmids indicated that the specific mutations were introduced with no additional mutations. All other clones generated from the PCR fragments described below were also sequenced for confirmation.
Protein interaction studies. His-Tag Drs2p C-tail and Gea2p-Sec7 (558-766) domain proteins were expressed in BL21(DE3) Escherichia coli at 30 °C in the presence of 1 mM IPTG for 3.5-4.0 h. Then cells were lysed by sonication with protease inhibitor and 10 mM β-mercaptoethanol. His-Tag proteins were purified by Ni-NTA affinity chromatography and eluted with 250 mM imidazole in 20 mM HEPES pH 7.5 and 250 mM NaCl. Proteins were further purified for pulldown assays using HiTrap SP and Q columns (GE Life Sciences) for His-tag Drs2p C-tail and Gea2p-Sec7, respectively. His-Tag Drs2p mutant C-tail proteins were purified by using a PD-10 desalting column (GE Life Sciences). The His-tag Gea2p-Sec7 protein was cleaved by thrombin digestion (RECOMT Thrombin CleanCleave Kit, Sigma).Uncleaved protein was subsequently removed by Ni-NTA agarose. SDS-PAGE and Coomassie staining were used to assess purity of the proteins.
Ni-NTA Agarose (Qiagen) in binding buffer (20 mM HEPES pH 7.5, 250 mM NaCl, and 50 mM Imidazole) was mixed with 1.5 μg of His-tagged Drs2p-C-tail proteins and rotated for 20 min at 25 °C to bind the proteins to the beads. After the beads were washed three times with binding buffer, 1 or 2 μg of Gea2p-Sec7 protein was added, rotated for 15 min at 25 °C and washed three times with binding buffer. As a negative control, 1 or 2 μg of Gea2p-Sec7 was incubated with Ni-NTA agarose beads in binding buffer. Bound proteins were eluted with SDS sample buffer and analysed by SDS-PAGE with bovine serum albumin (BSA) as a standard. The Odyssey infrared imaging system was used to quantify Coomassie stained bands. The amount of Gea2p-Sec7 bound to beads alone was subtracted from the amount bound to Drs2p-C-tail. This value was divided by the amount of Drs2p-C-tail in the lanes and the ratio (Gea2-Sec7/Drs2p-C-tail) was plotted (n =3).
For the protein-lipid overlay assay, 8 ng of His-tagged fusion proteins were incubated with PIP strips (Echelon Biosciences) for 1 h at room temperature, according to the manufacturers protocol. The amount of His-tagged protein bound to each lipid spot was quantified using rabbit anti-His antibody followed by Alexa Fluor 680 goat anti-rabbit IgG and the Odyssey infrared imaging system. Data were normalized to the amount of His-Drs2CT protein (RMKKQR) bound to PtdIns(4)P.
Phospholipid binding assays. Liposomes were composed of egg yolk phosphatidylcholine (65 mol%), phosphatidylethanolamine (20%), NBD-PtdCho (1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]sn-glycero-3-phosphocholine (2%), and ergosterol (10%) with 3% of either brain phosphatidylserine, soybean phosphotidylinositol, phosphatidylinositol-3-phosphate, phosphatidylinositol-4-phosphate or phosphatidylinositol-5phosphate. Lipids as stock solutions in chloroform (Avanti Polar Lipids and Echelon Biosciences) were mixed and the solvent was removed by flushing with compressed nitrogen gas. The lipid film was hydrated in 50 mM Hepes, pH 7.0, 120 mM K-acetate (HK buffer) giving a suspension of large multilamellar liposomes (lipid concentration 0.5 mg ml -1 ). The suspension was then frozen and thawed 5 times (using liquid nitrogen and a 40 °C water bath) and then extruded 10 times through 100 nm pore size polycarbonate filters using a mini-extruder (Avanti Polar Lipids). NBD fluorescence was used to estimate the amount of lipid recovered after extrusion.
For protein-liposome binding assays, liposomes (496 μM phospholipid) and proteins (0.621 μM) were mixed to a final volume of 150 μl and kept at room temperature for 5 min. After incubation, the samples were subjected to flotation in a sucrose step gradient as previously described 31 . NBD-PtdCho fluorescence was measured for each fraction to identify the liposome peak. The amount of His-tagged proteins in the liposome fractions (from the top of the gradient) was determined by spotting the samples onto immobilon membranes (Whatman) and probing with rabbit anti-His antibody (1:1000, Santa Cruz Biotechnology) followed by Alexa Fluor 680 goat anti-rabbit IgG (1:4000, Invitrogen Corporation). For the blank sample, the His-tagged proteins were mock incubated in the absence of liposomes and subjected to the step gradient. The amount of liposome-bound protein was quantified using the Odyssey infrared imaging system and normalized to the amount of His-Drs2-CT protein (RMKKQR) bound to liposomes containing PtdIns(4)P (set to 100%).
PtdIns kinase assay. TGN membranes (5 μg protein) were incubated at 27 °C or 37 °C for 2 h before adding kinase assay buffer (20 mM HEPES, pH7.5, 10 mM MgCl 2 , 0.2 mg ml -1 sonicated PtdIns, 60 μM ATP and 2 μCi γ-32 P-ATP) to a final volume of 50 μl. Samples were incubated with γ-32 P-ATP for 5 min at 25 °C before phosphoinositides were extracted from the membranes and separated on TLC plates using the borate system 32 .
Circular dichroism (CD). These measurements were performed on a Jasco J-810 spectropolarimeter at room temperature using a thin quartz cell (path length 0.1 cm). Before taking CD spectra, protein precipitates were pelleted by centrifugation at 438,178g for 1h in a fixed angle rotor (Beckman TLA 100.3) and the supernatant was dialysed against 10 mM Tris, pH 7.5, 250 mM KCl to remove the 
Figure S2
Quantification of His-tagged Drs2p-C-tail interaction with phospholipids. a, Quantification of His-tagged Drs2p-C-tail (residues 1219 -1305) containing either the wild-type basic patch (RMKKQR) or basic residue -> alanine mutations (AMAAQA) association with lipids immobilized on nitrocellulose (PIP strips). The amount of His-tagged protein bound to each lipid spot was quantified using rabbit anti-His antibody followed by Alexa Fluor® 680 goat anti-rabbit IgG and the Odyssey infrared imaging system. The WT C-tail binding to PI4P was set to 100% and used to normalize the signals for other lipids. b, Binding of wild-type (RMKKQR) or mutant (AMAAQA) Drs2p C-tail to PtdCho/PtdEth liposomes containing either 3 mol% PtdSer, PtdIns, PtdIns3P, PtdInsP or PtdIns5P 5 . The graphs in a and b depict average ± SD (n=3).
Figure S3
Expression and stability of Drs2p mutant proteins and Golgi associated Gea proteins. a, Cell lysates (0.2 OD) and 10 ng of Golgi membrane protein from WT and the drs2 mutant strains indicated were analyzed by western blotting with anti-Drs2p antibody. b, 50ng of Golgi membrane protein from WT, gea1∆ and gea2∆ strains were analyzed by western blotting with anti-Gea1p antibody. c, NBD-PS flippase activity in purified TGN membranes (wild-type) with or without 0.3 mM Brefeldin A. 
